Lung Cancer Foundation of America (LCFA) and the International Association for the Study of Lung Cancer (IASLC) Amplify Their Commitment to Nurturing Emerging Talent in Lung Cancer Research
02 mai 2024 08h00 HE
|
Lung Cancer Foundation of America
Los Angeles, CA, May 02, 2024 (GLOBE NEWSWIRE) -- In a significant stride towards unlocking the complexities of lung cancer that may lead to the next breakthrough treatment, Lung Cancer Foundation...
Young Lung Cancer Investigator Awarded a $200,000 Grant to Support Research in Translational Immuno-oncology
05 avr. 2023 13h24 HE
|
Lung Cancer Foundation of America
Los Angeles, CA, April 05, 2023 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE Lung Cancer Foundation of America (LCFA) and the International Association for the Study of Lung...
Young Investigators awarded $200k to study innovative new ways to engage the body’s immune system to fight lung cancer
15 janv. 2021 05h03 HE
|
Lung Cancer Foundation of America
Los Angeles, CA, Jan. 15, 2021 (GLOBE NEWSWIRE) -- Two new $200,000 grant-funded studies supported by the Lung Cancer Foundation of America, the International Lung Cancer Foundation, and generously...
Two Young Investigators awarded $200,000 grants to make immunotherapy more effective for lung cancer patients
15 avr. 2020 18h00 HE
|
Lung Cancer Foundation of America
LOS ANGELES, CA, April 15, 2020 (GLOBE NEWSWIRE) -- Two young investigators, Triparna Sen, Ph.D. and Jon Zugazagoitia M.D., Ph.D., will each receive $200,000 grants to study ways to make...
Young Investigators awarded $200k to study how the body’s own defense mechanisms may be used in the fight against lung cancer
06 déc. 2019 05h07 HE
|
Lung Cancer Foundation of America
Los Angeles, CA, Dec. 06, 2019 (GLOBE NEWSWIRE) -- Two new $200,000 grant-funded studies supported by the Lung Cancer Foundation of America, the International Lung Cancer Foundation, and generously...
BluePrint Phase 2 Demonstrates Digital Pathology Review Equivalent to Glass Slides
17 oct. 2017 21h45 HE
|
Histogenex LLC
YOKOHAMA, Japan, Oct. 17, 2017 (GLOBE NEWSWIRE) -- The BluePrint Phase 2 committee today presented its findings comparing five PD-L1 IHC assays at the International Association for the Study of Lung...
Zusammenfassung der Forschungspräsentationen bei der 17. Welt-Lungenkrebs-Konferenz der Internationalen Vereinigung für das Studium von Lungenkrebs (International Association for the Study of Lung Cancer, IASLC) am Dienstag, dem 6. Dezember 2016
07 déc. 2016 04h58 HE
|
IASLC
WIEN, ÖSTERREICH--(Marketwired - 7. Dezember 2016) - Die heutige Presseinformation zur 17. Welt-Lungenkrebs-Konferenz (World Conference on Lung Cancer, WCLC) der IASLC setzte den Akzent auf aktive...
Resumen de las presentaciones de investigación de la 17ª Conferencia Mundial sobre el Cáncer de Pulmón de la IASLC, martes 6 de diciembre de 2016
06 déc. 2016 22h07 HE
|
IASLC
VIENA, AUSTRIA--(Marketwired - 6 de diciembre de 2016) - La rueda de prensa de hoy en la 17ª Conferencia Mundial sobre Cáncer de Pulmón (WCLC) de la IASLC se centró en la prevención activa. Los...
Résumé des présentations d'études de la 17e Conférence mondiale sur le cancer du poumon de l'IASLC (mardi 6 décembre 2016)
06 déc. 2016 20h06 HE
|
IASLC
VIENNE, AUTRICHE--(Marketwired - 6 décembre 2016) - Le point-presse d'aujourd'hui à l'occasion de la 17e Conférence mondiale sur le cancer du poumon (WCLC) de l'IASLC s'est concentré sur la...
Resumo das Apresentações das Pesquisas na IASLC 17a Conferência Mundial sobre Câncer de Pulmão de terça-feira, dia 6 de dezembro de 2016
06 déc. 2016 18h33 HE
|
IASLC
VIENNA, AUSTRIA--(Marketwired - 6 de dezembro de 2016) - A coletiva com a mídia de hoje na IASLC 17a Conferência Mundial sobre o Câncer de Pulmão (World Conference on Lung Cancer - WCLC)...